- Home
- FMX vs ZTS Comparison
FMX vs ZTS Comparison
Compare FMX & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMX | ZTS |
|---|---|---|
| Founded | 1890 | 1952 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1B | 32.5B |
| IPO Year | 1998 | 2012 |
Fundamental Metrics
Financial Performance| Metric | FMX | ZTS |
|---|---|---|
| Price | $116.84 | $72.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $113.17 | ★ $154.18 |
| AVG Volume (30 Days) | 318.1K | ★ 3.7M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.30% | 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | N/A | ★ 3.08 |
| Revenue | N/A | ★ $9,467,000,000.00 |
| Revenue This Year | $10.20 | $5.63 |
| Revenue Next Year | $8.32 | $4.77 |
| P/E Ratio | $40.94 | ★ $23.81 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $89.54 | $71.00 |
| 52 Week High | $141.47 | $149.75 |
Technical Indicators
Market Signals| Indicator | FMX | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 38.21 | 41.90 |
| Support Level | $116.90 | $71.24 |
| Resistance Level | $118.82 | $78.74 |
| Average True Range (ATR) | 2.36 | 1.90 |
| MACD | -0.06 | -0.34 |
| Stochastic Oscillator | 2.76 | 13.52 |
Price Performance
Historical ComparisonAbout FMX Fomento Economico Mexicano S.A.B. de C.V.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.